Metformin

A biguanide medication that helps lower blood sugar levels by improving insulin sensitivity and decreasing glucose production in the liver.

Vildagliptin

A dipeptidyl peptidase-4 (dpp-4) inhibitor that enhances the body's natural incretin hormones, leading to increased insulin release and decreased glucagon secretion.

Treatment of type 2 diabetes mellitus in adults, particularly when metformin alone is insufficient to control blood sugar levels.

Vildagliptin 100mg And Metformin Hydrochloride (Sustained Release) 1000mg Tablets (Metformin + Vildagliptin) work synergistically to improve blood sugar control. Metformin reduces hepatic glucose production and improves insulin sensitivity, while vildagliptin enhances the incretin effect, leading to increased insulin secretion and reduced glucagon release. This combined action leads to better glycemic control than either drug alone.

Store at room temperature (below 30°C), away from moisture and direct sunlight. Keep out of reach of children.

Dosage should be determined by a healthcare professional based on individual needs and response to treatment.

Typically started at a lower dose and gradually increased as tolerated.

Follow the prescribed dosage and administration schedule carefully.

Take with food to minimize gastrointestinal side effects.

Hypoglycemia (low blood sugar) – especially when combined with other diabetes medications or if fasting.

Gastrointestinal issues (nausea, vomiting, diarrhea, abdominal pain)

Headache

Dizziness

Fatigue

Allergic reactions (rash, itching, swelling)

Alcohol Consumption

Alcohol consumption should be limited as it can increase the risk of hypoglycemia and lactic acidosis.



While Driving or operating Machinery

May cause dizziness or fatigue, affecting ability to drive or operate machinery. Exercise caution.



Pregnant & Breastfeeding Women

Not recommended during pregnancy or breastfeeding. Consult your doctor.



Children

Not indicated for use in children.



Kidney

Renal function should be monitored regularly, as metformin is primarily excreted through the kidneys. Dosage adjustments may be necessary in patients with impaired kidney function.



Liver

Liver function should be monitored, especially in patients with liver disease. Metformin may be contraindicated in severe liver impairment.

Please consult your physician or pharmacist for specific product information and references.